BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphoma-Reference-Cited by-同舟云学术

BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphoma

Published:2011-12 Issue:12 Volume:10 Page:1661-1669
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Villanueva Helena,de Cerio Ascension Lopez-Diaz,Inoges Susana,Pastor Fernando,Soldevilla Mario Martinez,Bendandi Maurizio

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1586/erv.11.132

Reference41 articles.

1. Swerdlow SH, Campo E, Harris NLet al.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition). IARC Press, Lyon, France (2008).

2. Aiming at a Curative Strategy for Follicular Lymphoma

3. Mantle cell lymphoma: The promise of new treatment options

4. Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures

5. Idiotype Vaccines for Human B-Cell Malignancies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives;Computational and Structural Biotechnology Journal;2024-12

2. Novel Immunotherapies for Hematological Malignancies;Current Molecular Pharmacology;2016-09-05

3. Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination;Current Topics in Microbiology and Immunology;2016

4. Current World Literature;Current Opinion in Oncology;2012-09

5. Conference Scene: Immune signatures in the tumor and beyond;Immunotherapy;2012-08